Participant Survey.pdf (268.66 kB)

Supplementary Material – Attitudes towards pharmacogenetics in patients undergoing CYP2C19 testing following percutaneous coronary intervention

dataset

posted on 11.01.2022, 14:37 authored by Figshare Future Science GroupFigshare Future Science Group, Grace Lee, Lisa A. Varughese, Laura Conway, Carol Stojinski, Sandhya Ashokkumar, Karen Monono, William Matthai, Daniel M. Kolansky, Jay Giri, Sony Tuteja

Participant Survey – Pharmacogenetic Testing

Funding

National Heart Lung Blood Institute K23HL143161

National Center for Advancing Translational Sciences TL1TR001880

History

Usage metrics

Read the peer-reviewed publication

Attitudes towards pharmacogenetics in patients undergoing CYP2C19 testing following percutaneous coronary intervention

Personalized Medicine

Categories

Keywords

pharmacogenetics precision medicine pharmacogenetic testing clopidogrel cytochrome P450 CYP2C19 patient attitudes survey patient acceptance of healthcare Pharmacogenomics Medical Genetics (excl. Cancer Genetics)Cardiology (incl. Cardiovascular Diseases)

Licence

CC BY-NC-ND 4.0

Exports